All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Listed as ongoing, but also has a completion date | 2004-000353-38 | A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with clear cell RCC and high risk of recurrence | 2012-10-31 | bad-data |
Listed as ongoing, but also has a completion date | 2006-005314-12 | A randomised, open label, Phase II Proof of Concept study of WX-671 in combination with gemcitabine vs gemcitabine in patients with locally advanced, non-resectable pancreatic cancer in order to evalu... | 2010-02-25 | bad-data |
Not reported | 2007-006078-27 | A PHASE 2, TWO-ARM, DOUBLE-BLIND, MULTICENTER, RANDOMIZED STUDY OF THE COMBINATION OF ORAL WX-671 PLUS CAPECITABINE VS. CAPECITABINE MONOTHERAPY IN FIRST-LINE HER2-NEGATIVE METASTATIC BREAST CANCER | 2013-06-15 | due-trials |
Exempt Terminated | 2011-003408-19 | A Phase I/II, open-label, dose-escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of the MEK inhibitor WX-554 in patients with solid tumours | 2014-03-28 | not-yet-due |